SOD1 and amyotrophic lateral sclerosis: These findings suggest that the ALS-associated hSOD1<sup>G93A</sup> mutation, when expressed solely in the gut epithelium, is not sufficient to initiate neuromuscular degeneration of systemic ALS-like pathology.